geko® T3 clinical trials

The RETRAIN Trial Phase 2

This study looks at how two devices, the geko® and IPC, affect blood flow and oxygen in the brain after a stroke. It aims to see if they can help improve recovery by boosting brain circulation in the first 36 hours after a stroke.